Efficacy of olokizumab against comorbid depressive disorder in patients with rheumatoid arthritis: Preliminary results of the study

Efficacy of olokizumab against comorbid depressive disorder in patients with rheumatoid arthritis: Preliminary results of the study

Background. Interleukin (IL) 6 plays an important role in the pathogenesis of comorbid rheumatoid arthritis (RA) depression, and IL-6 inhibitors (i) used to treat RA patients may have an antidepressant effect.Objective – to evaluate the effectiveness of Russian iIL-6 olokizumab (OKZ) in reducing sym...

Full description

Saved in:
Bibliographic Details
Main Authors: T. A. Lisitsyna, A. A. Abramkin, D. Yu. Veltishchev, O. F. Seravina, O. B. Kovalevskaya, A. B. Borisova, V. G. Ignatiev, E. L. Nasonov
Format: Article
Language:Russian
Published: IMA PRESS LLC 2023-04-01
Series:Научно-практическая ревматология
Subjects:
interleukin-6
rheumatoid arthritis
depression
cognitive disorders
olokizumab
Online Access:https://rsp.mediar-press.net/rsp/article/view/3321
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://rsp.mediar-press.net/rsp/article/view/3321

Similar Items